293 related articles for article (PubMed ID: 32007952)
21. SMYD3 as an oncogenic driver in prostate cancer by stimulation of androgen receptor transcription.
Liu C; Wang C; Wang K; Liu L; Shen Q; Yan K; Sun X; Chen J; Liu J; Ren H; Liu H; Xu Z; Hu S; Xu D; Fan Y
J Natl Cancer Inst; 2013 Nov; 105(22):1719-28. PubMed ID: 24174655
[TBL] [Abstract][Full Text] [Related]
22. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.
Metalli D; Lovat F; Tripodi F; Genua M; Xu SQ; Spinelli M; Alberghina L; Vanoni M; Baffa R; Gomella LG; Iozzo RV; Morrione A
Am J Pathol; 2010 Jun; 176(6):2997-3006. PubMed ID: 20395438
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of the SMYD3 Promotes Proliferation, Migration, and Invasion of Pancreatic Cancer.
Zhu CL; Huang Q
Dig Dis Sci; 2020 Feb; 65(2):489-499. PubMed ID: 31441002
[TBL] [Abstract][Full Text] [Related]
24. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
[TBL] [Abstract][Full Text] [Related]
25. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.
Genua M; Xu SQ; Buraschi S; Peiper SC; Gomella LG; Belfiore A; Iozzo RV; Morrione A
PLoS One; 2012; 7(6):e40148. PubMed ID: 22859931
[TBL] [Abstract][Full Text] [Related]
26. p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
Jin H; Xie Q; Guo X; Xu J; Wang A; Li J; Zhu J; Wu XR; Huang H; Huang C
J Biol Chem; 2017 Sep; 292(38):15952-15963. PubMed ID: 28794159
[TBL] [Abstract][Full Text] [Related]
27. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
28. SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Cock-Rada AM; Medjkane S; Janski N; Yousfi N; Perichon M; Chaussepied M; Chluba J; Langsley G; Weitzman JB
Cancer Res; 2012 Feb; 72(3):810-20. PubMed ID: 22194464
[TBL] [Abstract][Full Text] [Related]
29. HBXIP accelerates glycolysis and promotes cancer angiogenesis via AKT/mTOR pathway in bladder cancer.
Liu X; Li H; Che N; Zheng Y; Fan W; Li M; Li X; Xuan Y
Exp Mol Pathol; 2021 Aug; 121():104665. PubMed ID: 34216584
[TBL] [Abstract][Full Text] [Related]
30. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
[TBL] [Abstract][Full Text] [Related]
31. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
[TBL] [Abstract][Full Text] [Related]
32. A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.
Oh SH; Kang JH; Kyu Woo J; Lee OH; Kim ES; Lee HY
Int J Cancer; 2012 Aug; 131(3):537-47. PubMed ID: 22113431
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
34. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
Zhang L; Wang CZ; Ma M; Shao GF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
[TBL] [Abstract][Full Text] [Related]
35. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma.
Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W
Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550
[TBL] [Abstract][Full Text] [Related]
36. miR-455-5p suppresses hepatocellular carcinoma cell growth and invasion via IGF-1R/AKT/GLUT1 pathway by targeting IGF-1R.
Hu Y; Yang Z; Bao D; Ni JS; Lou J
Pathol Res Pract; 2019 Dec; 215(12):152674. PubMed ID: 31732382
[TBL] [Abstract][Full Text] [Related]
37. SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Fenizia C; Bottino C; Corbetta S; Fittipaldi R; Floris P; Gaudenzi G; Carra S; Cotelli F; Vitale G; Caretti G
Nucleic Acids Res; 2019 Feb; 47(3):1278-1293. PubMed ID: 30544196
[TBL] [Abstract][Full Text] [Related]
38. SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters.
Lyu T; Jiang Y; Jia N; Che X; Li Q; Yu Y; Hua K; Bast RC; Feng W
Int J Cancer; 2020 Mar; 146(6):1553-1567. PubMed ID: 31503345
[TBL] [Abstract][Full Text] [Related]
39. Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.
Bettiga A; Aureli M; Colciago G; Murdica V; Moschini M; Lucianò R; Canals D; Hannun Y; Hedlund P; Lavorgna G; Colombo R; Bassi R; Samarani M; Montorsi F; Salonia A; Benigni F
Sci Rep; 2017 Feb; 7():42157. PubMed ID: 28191815
[TBL] [Abstract][Full Text] [Related]
40. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]